Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Dramatic improvement in cadaver donor graft survival of North American children.

Go back to Resources

Dramatic improvement in cadaver donor graft survival of North American children.

Authors:

Go back to Resources

Development and valuation of a food frequency questionnaire in a randomized trial of eye diseases.

Go back to Resources

Development and valuation of a food frequency questionnaire in a randomized trial of eye diseases.

Authors:

Location:

Go back to Resources

Development and valuation of a food frequency questionnaire in a randomized trial of eye diseases

Go back to Resources

Development and valuation of a food frequency questionnaire in a randomized trial of eye diseases

Authors:

Go back to Resources

Development and validation of a food frequency questionnaire in a randomized trial of eye diseases.

Go back to Resources

Development and validation of a food frequency questionnaire in a randomized trial of eye diseases.

Authors:

Go back to Resources

Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type1 envelope with a combination vaccine regimen

Go back to Resources

Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type1 envelope with a combination vaccine regimen

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Waiting list mortality for pediatric patients with chronic liver disease.

Go back to Resources

Waiting list mortality for pediatric patients with chronic liver disease.

Authors:

Go back to Resources

Updated multivariate analyses of patient characteristics as predictors of survival in hormone-refractory prostate cancer patients treated with suramin

Go back to Resources

Updated multivariate analyses of patient characteristics as predictors of survival in hormone-refractory prostate cancer patients treated with suramin

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Trend in immunosuppressive therapy: A report of the North American Pediatric Cooperative Study (NAPRTCS)

Go back to Resources

Trend in immunosuppressive therapy: A report of the North American Pediatric Cooperative Study (NAPRTCS)

Authors:

Location:

Go back to Resources

The relationship between the duration of storage of platelets and the development of transfusion reactions

Go back to Resources

The relationship between the duration of storage of platelets and the development of transfusion reactions

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparious women

Go back to Resources

The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparious women

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 112
  • Page 113
  • Page 114
  • Page 115
  • Current page 116
  • Page 117
  • Page 118
  • Page 119
  • Page 120
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • ISO Certification